virosome vaccine

virosome vaccine

A 'designer' vaccine for influenza in which hemagglutinin is extracted from the influenza virus and incorporated into the membrane of liposomes composed of phosphatidylcholine and phosphatidylethanol-amine
References in periodicals archive ?
The resulting virosome vaccine can attach to and fuse with host cells, but lacking genetic material, it can't replicate or harm the bird.
A promising alternative that is in an earlier stage of development involves the virosome vaccine.
in December 2013, which will fund the development of a virosome vaccine technology licensed from Mymetics Corp.
To overcome those problems, Kapcyznski and his colleagues at the Southeast Poultry Research Laboratory in Athens, Georgia, developed what's known as a nonreplicating virosome vaccine.
The virosome vaccine is composed of liposomes, water insoluble spheres encased in lipid layers.
Birds in the control group did not survive the challenge, but birds that received either the live-virus or virosome vaccine were 100 percent protected from the END virus.
The next step for Kapczynski and his colleagues is to determine whether the virosome vaccine can protect a typical commercial flock, which is exposed to various production and environmental stresses, such as other illnesses and temperature fluctuations.
5 years and brings together global expertise in the field of virosome vaccines, manufacturing, spray drying, freeze drying and analytical techniques from the pharma industry.